s 12363 has been researched along with Neutropenia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adenis, A; Bonneterre, J; Fumoleau, P; Giroux, B; Marty, M; Pion, JM; Pouillart, P | 1 |
1 trial(s) available for s 12363 and Neutropenia
| Article | Year |
|---|---|
Phase II study of a new vinca alkaloid derivative, S12363, in advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Injections, Intravenous; Middle Aged; Neutropenia; Vinca Alkaloids | 1995 |